The vaccine maker's latest leg up pairs a planned NIH cancer vaccine initiative with index-fund demand, and the rally may not be done.

The chip giant filed for a Nasdaq listing plan that could raise $29.4 billion, instantly reshaping investor expectations.

The IPO flips expectations: a rocket company lands among megacaps even while revenue is far smaller.

A Nasdaq opening pop turns SpaceX into a public company overnight, forcing new money questions fast.

The IPO priced at $135, surged on Nasdaq and Texas, and immediately rewired how executives think about mega-debuts.

Forced buyers and tracker funds could amplify buying pressure as SpaceX joins the Nasdaq index on a rule tweak.

The SPCX listing breaks records, but Japanese household investors quietly took a meaningful chunk of the biggest payday ever.

The IPO lands on Nasdaq as critics question Musk’s near-absolute ownership, and the filings force boards to look hard.

The Nasdaq leads a broad selloff as investors question the billions poured into AI compute after a Chinese model upends cost assumptions.